116 related articles for article (PubMed ID: 7545771)
1. Effects of inhibition of nitric oxide synthesis on TNF alpha serum levels in E. coli endotoxemic rats.
Boczkowski J; Philip I; Tedgui A; Bernard C; Merval R; Desmonts JM; Aubier M
Life Sci; 1995; 57(13):PL147-52. PubMed ID: 7545771
[TBL] [Abstract][Full Text] [Related]
2. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo.
Laszlo F; Evans SM; Whittle BJ
Eur J Pharmacol; 1995 Jan; 272(2-3):169-75. PubMed ID: 7536162
[TBL] [Abstract][Full Text] [Related]
3. Induction of hepatic Ito cell nitric oxide production after acute endotoxemia.
Helyar L; Bundschuh DS; Laskin JD; Laskin DL
Hepatology; 1994 Dec; 20(6):1509-15. PubMed ID: 7527004
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of nitric oxide formation by guanidines.
Hasan K; Heesen BJ; Corbett JA; McDaniel ML; Chang K; Allison W; Wolffenbuttel BH; Williamson JR; Tilton RG
Eur J Pharmacol; 1993 Nov; 249(1):101-6. PubMed ID: 7506664
[TBL] [Abstract][Full Text] [Related]
5. Aminoguanidine selectively inhibits inducible nitric oxide synthase.
Griffiths MJ; Messent M; MacAllister RJ; Evans TW
Br J Pharmacol; 1993 Nov; 110(3):963-8. PubMed ID: 7507781
[TBL] [Abstract][Full Text] [Related]
6. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock.
Klemm P; Thiemermann C; Winklmaier G; Martorana PA; Henning R
Br J Pharmacol; 1995 Jan; 114(2):363-8. PubMed ID: 7533615
[TBL] [Abstract][Full Text] [Related]
7. Effects of guanidino and uremic compounds on nitric oxide pathways.
MacAllister RJ; Whitley GS; Vallance P
Kidney Int; 1994 Mar; 45(3):737-42. PubMed ID: 7515129
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide synthase in experimental gram-negative sepsis.
Evans T; Carpenter A; Silva A; Cohen J
J Infect Dis; 1994 Feb; 169(2):343-9. PubMed ID: 7508968
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide production by Sertoli cells in response to cytokines and lipopolysaccharide.
Stéphan JP; Guillemois C; Jégou B; Bauché F
Biochem Biophys Res Commun; 1995 Aug; 213(1):218-24. PubMed ID: 7543752
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthesis and the effect of aminoguanidine and NG-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat.
Wu G
Diabetes; 1995 Mar; 44(3):360-4. PubMed ID: 7533735
[TBL] [Abstract][Full Text] [Related]
12. Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta.
Joly GA; Ayres M; Chelly F; Kilbourn RG
Biochem Biophys Res Commun; 1994 Feb; 199(1):147-54. PubMed ID: 7510104
[TBL] [Abstract][Full Text] [Related]
13. Is endotoxin-induced hypotension related to nitric oxide formation?
Preiser JC; Zhang H; Wachel D; Boeynaems JM; Buurman W; Vincent JL
Eur Surg Res; 1994; 26(1):10-8. PubMed ID: 7511103
[TBL] [Abstract][Full Text] [Related]
14. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
[TBL] [Abstract][Full Text] [Related]
15. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.
Radomski MW; Vallance P; Whitley G; Foxwell N; Moncada S
Cardiovasc Res; 1993 Jul; 27(7):1380-2. PubMed ID: 7504587
[TBL] [Abstract][Full Text] [Related]
16. The effects of nitric oxide inhibition on regional hemodynamics during hyperdynamic endotoxemia.
Henderson JL; Statman R; Cunningham JN; Cheng W; Damiani P; Siconolfi A; Horovitz JH
Arch Surg; 1994 Dec; 129(12):1271-4; discussion 1275. PubMed ID: 7527209
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibition reduces wakefulness.
Dzoljic MR; De Vries R
Neuropharmacology; 1994 Nov; 33(11):1505-9. PubMed ID: 7532835
[TBL] [Abstract][Full Text] [Related]
18. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Tilton RG; Chang K; Hasan KS; Smith SR; Petrash JM; Misko TP; Moore WM; Currie MG; Corbett JA; McDaniel ML
Diabetes; 1993 Feb; 42(2):221-32. PubMed ID: 7678825
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors.
Laszlo F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Apr; 111(4):1309-15. PubMed ID: 7518298
[TBL] [Abstract][Full Text] [Related]
20. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis.
Chan J; Tanaka K; Carroll D; Flynn J; Bloom BR
Infect Immun; 1995 Feb; 63(2):736-40. PubMed ID: 7529749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
